Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection

Lignende værker

• Encapsulation of an EP67-conjugated CTL peptide vaccine in nanoscale biodegradable particles increases the efficacy of respiratory immunization and affects the magnitude and memory subsets of vaccine-generated mucosal and systemic CD8(+) T cells in a diameter-dependent manner
  af: Karuturi, Bala V. K., et al.
  Udgivet: (2017)
• Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant
  af: Karuturi, Vamsi K., et al.
  Udgivet: (2015)
• Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67
  af: Alshammari, Abdulraman M., et al.
  Udgivet: (2020)
• Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS
  af: Tseng, Chin-Chung, et al.
  Udgivet: (2018)
• Barium-Encapsulated Biodegradable Polycaprolactone for Sulfate Removal
  af: Changseok Han, et al.
  Udgivet: (2018-12-01)